Welcome to the Ulcerative Colitis Resource Center, brought to you by Healio.com/Gastroenterology. Here you'll find the latest information on the diagnosis, management and treatment of ulcerative colitis, as well as up-to-date material on future research. Be sure to check out Healio.com/Gastroenterology for more news and perspective important to your practice.
In the Journals
January 16, 2020
Remicade ranked highest for induction of remission and endoscopic improvement among biologic-naive patients, according to a meta-analysis of…
In the Journals
December 30, 2019
Assessing bowel wall thickness with intestinal ultrasound can be a helpful tool to monitor therapeutic response in patients with ulcerative colitis…
FDA NewsPerspective
December 13, 2019
The FDA on Thursday approved Xeljanz extended release 11 mg and 22 mg tablets for the once daily treatment of adults with moderately to severely…
Meeting News
December 10, 2019
SAN ANTONIO — Researchers investigating racial disparities in health care found no significant difference in the use of biologics or other…
Meeting News
December 9, 2019
SAN ANTONIO — In patients with inflammatory bowel disease, first-line vedolizumab treatment did not appear to compromise the effectiveness of…
Meeting News
November 19, 2019
SAN ANTONIO — A post hoc analysis evaluating the safety of Xeljanz in ulcerative colitis revealed comparable incidence rates of pulmonary…
Meeting News
November 12, 2019
SAN ANTONIO — The odds of inpatient mortality were nearly four times higher among geriatric adults than adults aged younger than 75 years who…
Meeting News
November 8, 2019
SAN ANTONIO — Entyvio was associated with significantly fewer serious adverse events and serious infections compared with anti-TNF therapy in…
Meeting News
November 6, 2019
SAN ANTONIO — Older patients with Crohn’s disease were less likely to receive biologic agents and more than twice as likely to receive…
Meeting NewsVideo
November 5, 2019
SAN ANTONIO — In this video from the American College of Gastroenterology Annual Meeting, David T. Rubin, MD, section chief of…